Pluri (PLUR) Cost of Revenue (2011 - 2025)
Pluri (PLUR) posted quarterly Cost of Revenue of $497000.0 for Q4 2025, up 82.05% year-over-year from $273000.0 in Q4 2024, and up 147.26% quarter-over-quarter from $201000.0 in Q3 2025.
Pluri (PLUR) Cost of Revenue (2011 - 2025) Analysis & Trends
Pluri (PLUR) has reported Cost of Revenue for 11 consecutive years, with $497000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cost of Revenue rose 82.05% year-over-year to $497000.0; the TTM figure through Dec 2025 stood at $1.2 million (up 192.8% YoY), while the FY2025 annual figure was $682000.0, up 16950.0% from the prior year.
- Cost of Revenue climbed to $497000.0 in Q4 2025 per PLUR's latest filing, from $201000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $497000.0 in Q4 2025 and bottomed at $4000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 | 497,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 497,000.00 |
| Dec 31, 2025 | 497,000.00 |
| Sep 30, 2025 | 201,000.00 |
| Sep 30, 2025 | 201,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Jun 30, 2025 | 191,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Mar 31, 2025 | 291,000.00 |
| Dec 31, 2024 | 273,000.00 |
| Dec 31, 2024 | 273,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Sep 30, 2024 | 126,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 4,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Jun 30, 2020 | -1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2019 | 1,000.00 |
| Dec 31, 2018 | 2,000.00 |
| Dec 31, 2018 | 2,000.00 |